The Pharmacologic Management of Anxiety Disorders in Primary Care is organized by Nurse Practitioner Associates for Continuing Education (NPACE).
Expiration Date: December 31, 2025
Description:
Given the limited access to mental health specialists, primary care practitioners must often diagnose, initiate treatment, and chronically manage different anxiety disorders. This presentation utilizes evidence-based medicine and case studies to discuss the underlying pathophysiology of anxiety and the different options of pharmaceuticals in the treatment of anxiety.
Learning Objectives:
After taking part in this educational activity, participants should be better able to:
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved